Protocol EAY191 Molecular Analysis for Combination Therapy Choice (ComboMATCH)
Primary Objective
This ComboMATCH patient screening trial. The study will identify patients with certain gene changes or mutations for treatment using a combination of targeted therapy.

Description
Patients that have a gene change or mutation that matches a certain treatment trial will be asked to be part of that treatment trial. This is a registration study.
Details
Locations
Greeley Campus
Harmony Campus
Medical Center of the Rockies
Poudre Valley Hospital
University of Colorado Hospital
Principal Investigator

Robert Lentz
Study ID
Protocol Number: 23-1254
More information available at ClinicalTrials.gov: NCT05564377
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers